Baxter Earns Recognition for Sustainability Performance and Disclosure

Baxter Earns Recognition for Sustainability Performance and Disclosure

tweet me:
.@baxter_intl earns recognition for #sustainability performance & disclosure
Monday, July 8, 2013 - 11:00am

DEERFIELD, Ill., July 8, 2013 /3BL Media/ – Baxter International Inc. (NYSE: BAX) today announced that based on its sustainability performance, Baxter was included for the 12th year in Corporate Responsibility magazine's 100 Best Corporate Citizens list. The annual survey draws from firms in the Russell 1000 Index and is based on more than 320 data points of publicly available information in seven categories: environment, climate change, employee relations, human rights, governance, finance and philanthropy.

Baxter placed second in the Environmental Tracking (ET) Scope 3 Disclosure Leader Award rankings and ranked 13 and 35 in the ET North America 300 and ET Global 800 Carbon Rankings, respectively, based on transparent, public disclosure of greenhouse gas emissions that follow reporting guidelines and are externally verified. These rankings are compiled by the Environmental Investment Organisation, an independent not-for-profit research body promoting carbon transparency and investment solutions designed to address climate change.

About Baxter
Baxter's commitment to sustainability spans more than three decades. The company is included in the Dow Jones Sustainability Index and has been recognized by Corporate Responsibility magazine as one of the 100 Best Corporate Citizens and Newsweek’s Green Rankings as the leading U.S. healthcare company. Baxter is a member of the Center for Health and the Global Environment at Harvard Medical School, Center for Corporate Citizenship at Boston College, and the Ethics & Compliance Officer Association. The company endorses the Ceres principles and is an Organizational Stakeholder of the Global Reporting Initiative. Further information about Baxter’s sustainability activities can be found at

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

   # # #